ATE487692T1 - Verfahren und verbindungen zum nachweis von medizinischen erkrankungen - Google Patents

Verfahren und verbindungen zum nachweis von medizinischen erkrankungen

Info

Publication number
ATE487692T1
ATE487692T1 AT05758946T AT05758946T ATE487692T1 AT E487692 T1 ATE487692 T1 AT E487692T1 AT 05758946 T AT05758946 T AT 05758946T AT 05758946 T AT05758946 T AT 05758946T AT E487692 T1 ATE487692 T1 AT E487692T1
Authority
AT
Austria
Prior art keywords
compounds
methods
medical diseases
detecting medical
provides methods
Prior art date
Application number
AT05758946T
Other languages
English (en)
Inventor
Ilan Ziv
Anat Shirvan
Original Assignee
Aposense Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aposense Ltd filed Critical Aposense Ltd
Application granted granted Critical
Publication of ATE487692T1 publication Critical patent/ATE487692T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/49—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/01—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton
    • C07C323/02—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/03—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrotherapy Devices (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT05758946T 2004-07-08 2005-07-07 Verfahren und verbindungen zum nachweis von medizinischen erkrankungen ATE487692T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58585204P 2004-07-08 2004-07-08
PCT/IL2005/000725 WO2006006156A2 (en) 2004-07-08 2005-07-07 Compounds/methods for detection of medical disorders

Publications (1)

Publication Number Publication Date
ATE487692T1 true ATE487692T1 (de) 2010-11-15

Family

ID=35784250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05758946T ATE487692T1 (de) 2004-07-08 2005-07-07 Verfahren und verbindungen zum nachweis von medizinischen erkrankungen

Country Status (6)

Country Link
US (1) US8101666B2 (de)
EP (1) EP1773762B1 (de)
JP (1) JP2008505884A (de)
AT (1) ATE487692T1 (de)
DE (1) DE602005024690D1 (de)
WO (1) WO2006006156A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5322527B2 (ja) * 2008-07-17 2013-10-23 浜松ホトニクス株式会社 アポトーシスの検出に適した化合物
US11286246B2 (en) 2015-07-24 2022-03-29 Aposense Ltd. Pro-drugs and related methods
JP7348064B2 (ja) 2017-01-09 2023-09-20 アポセンス リミテッド 分子を経膜送達するための化合物及び方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133303A1 (de) * 1981-08-22 1983-03-03 Chemische Fabrik Pfersee Gmbh, 8900 Augsburg Verfahren zur herstellung von perfluoralkylreste enthaltenden kondensationsprodukten, die so hergestellten kondensationsprodukte und deren verwendung
US4677241A (en) * 1986-08-15 1987-06-30 Chevron Research Company Olefin oligomerization process and catalyst
US6322446B1 (en) * 1999-12-10 2001-11-27 Elot, Inc. System and a method for operating on-line state lottery games
MXPA03006467A (es) 2001-01-17 2004-01-29 Guilford Pharm Inc Inibidores de naaladasa a base de tiol.
WO2004096120A2 (en) * 2003-05-01 2004-11-11 Nst Neurosurvival Technologies Ltd. Compounds that selectively bind to membranes of apoptotic cells
GB0327494D0 (en) 2003-11-26 2003-12-31 Amersham Plc Novel imaging agents

Also Published As

Publication number Publication date
EP1773762B1 (de) 2010-11-10
EP1773762A4 (de) 2008-12-10
WO2006006156A3 (en) 2006-12-07
US8101666B2 (en) 2012-01-24
US20070232702A1 (en) 2007-10-04
EP1773762A2 (de) 2007-04-18
JP2008505884A (ja) 2008-02-28
WO2006006156A2 (en) 2006-01-19
DE602005024690D1 (de) 2010-12-23

Similar Documents

Publication Publication Date Title
DE602005025106D1 (de) Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen
DE602005006990D1 (de) Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen
CY1118566T1 (el) Διαγνωση με χρηση ιντερφερονης τυπου 1
ATE511645T1 (de) Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme
GB2467467B (en) TAZ/WWTR1 for diagnosis and treatment of cancer
WO2006085984A3 (en) Immune cell biosensors and methods of using same
WO2006076025A3 (en) Immune cell biosensors and methods of using same
WO2008108803A3 (en) Immune cell biosensors and methods of using same
WO2006073682A3 (en) Diagnostic test
PL1838355T3 (pl) Ulepszone sposoby wygaszania dla procesu inaktywacji czerwonych krwinek
WO2004092405A3 (en) Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
EA201590833A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
ATE457773T1 (de) Mittel zur funktionalen wiederherstellung eines geschädigten nervensystems
EP1744162A4 (de) Krebsdiagnose und behandlung unter verwendung eines anti-robo1-antikörpers
DK2076588T3 (da) Ekspansionsfremgangsmåde til voksne stamceller fra blod, især perifert blod, og dermed forbundet anvendelse på det medicinske område
ATE454465T1 (de) In-vitro-verfahren zur identifizierung von verbindungen zur krebstherapie
DK2041576T3 (da) Differentiel cytokinekspression i humane cancere
WO2006047475A3 (en) Detection and analysis of ophthalmically-relevant fluorescent molecules
CY1119653T1 (el) Μεθοδος για ταυτοποιηση της ευαισθησιας ενος ασθενους σε θεραπεια αναστολης της τελομερασης
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
ATE487692T1 (de) Verfahren und verbindungen zum nachweis von medizinischen erkrankungen
ATE426813T1 (de) Verfahren zur dosierung von ngf zur in vitro diagnose von brustkrebs und therapeutische verwendung
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
WO2006117681A3 (en) Novel therapies and methods of screening for therapeutic compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties